CEFTRIAXONE VIATRIS 250 mg, powder for solution for injection 10 bottles of 10 ml
Active ingredients: Ceftriaxone, Ceftriaxone sodium heptahydrate
Commercialized according to BDPMDispensing in France: Prescription only
Powder for solution for injection10 bottles of 10 mlintramusculaire;intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CEFTRIAXONE VIATRIS 250 mg, poudre pour solution injectable
- Pharmaceutical form
- poudre pour solution injectable
- Route of administration
- intramusculaire;intraveineuse
- Presentation description
- 10 flacon(s) en verre de 10 ml
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 6 Jul 2001
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68646885CIP75627838CIP133400956278381Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CEFTRIAXONE SODIQUEpoudre | 298,3 mg · un flacon | SA |
| CEFTRIAXONE BASEpoudre | 250 mg · un flacon | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.